MT-ND5
Chr MTNADH dehydrogenase subunit 5
Also known as: MTND5
Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Located in mitochondrial inner membrane. Part of respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; Leigh disease; and MELAS syndrome. [provided by Alliance of Genome Resources, Jul 2025]
Primary Disease Associations & Inheritance
Clinical highlights
MT-ND5 is a mitochondrial protein-coding gene. gnomAD constraint, carrier burden and exome coverage, the ClinVar type breakdown, AlphaFold and transcript-architecture views are built for nuclear genes and are not shown. Population data for mtDNA variants (gnomAD v3.1, homoplasmy and heteroplasmy) is on each variant page.
Where it sits in the mitochondrial genome
Tap or hover a gene, landmark or tick; genes open their page, ticks their variant.
37 genes from Ensembl (rCRS numbering, matched to MITOMAP’s Gene Loci); landmarks and disease alleles from MITOMAP (CC BY 3.0). Circular layout after MitoWheel.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
MT-ND5 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
MITOMAP Disease Variants — MT-ND5
Live table ↗| Variant | AA | Disease | Status | GenBank seqs |
|---|---|---|---|---|
| m.12338T>C | M1T | DEAF1555 increased penetrance / LHON / MIDD | Conflicting reports | 230 |
| m.12350C>A | T5N | SNHL + neurodevelopmental delay | Reported | 0 |
| m.12361A>G | T9A | Non-alcoholic fatty liver disease | Reported | 438 |
| m.12372G>A | L12L | Altered brain pH / sCJD patients; AD risk in certain haplogroups | Benign · reported | 8,848 |
| m.12397A>G | T21A | PD, early onset | Reported | 405 |
| m.12414T>- | frameshift | EXIT | Reported | 0 |
| m.12425A>- | frameshift | Mitochondrial myopathy & renal failure | Likely pathogenic · confirmed | 2 |
| m.12477T>C | S47S | Possible HCM susceptibility / PCOS patients | Reported | 361 |
| m.12622G>A | V96I | Leigh Disease | Conflicting reports | 11 |
| m.12631T>A | S99T | found in 2 sCJD patients | Reported | 0 |
| m.12634A>G | I100V | Thyroid Cancer Cell Line | Reported | 251 |
| m.12635T>C | I100T | Suspected Leigh Disease | Reported | 2 |
| m.12662A>G | N109S | Recurrent pregnancy loss | Reported | 86 |
| m.12686T>A | F117Y | Dilated Cardiomyopathy | Reported | 0 |
| m.12705C>T | I123I | Possible protective factor for normal tension glaucoma | Reported | 27,627 |
| m.12706T>C | F124L | Leigh Disease | Likely pathogenic · confirmed | 0 |
| m.12770A>G | E145G | MELAS | Uncertain significance · reported | 1 |
| m.12778G>C | G148R | Dilated Cardiomyopathy | Reported | 0 |
| m.12782T>G | I149S | LHON | Reported | 0 |
| m.12811T>C | Y159H | Possible LHON factor | Benign · reported | 741 |
| m.12814G>T | A160S | LHON | Reported | 13 |
| m.12848C>T | A171V | LHON | Uncertain significance · reported | 0 |
| m.12858C>A | Y174Term | Unspecified suspected mitochondrial disorder | Reported | 0 |
| m.12923G>A | W196Term | LHON/MELAS/LS | Reported | 0 |
| m.12955A>G | N207D | EXIT and developmental delay | Reported | 0 |
| m.13042G>A | A236T | Optic neuropathy/ retinopathy/ LD | Likely pathogenic · confirmed | 2 |
| m.13045A>G | M237V | MELAS | Reported | 0 |
| m.13045A>C | M237L | MELAS / LHON / Leigh overlap syndrome | Uncertain significance · reported | 1 |
| m.13046T>C | M237T | LHON/MELAS overlap syndrome | Likely pathogenic · confirmed | 0 |
| m.13051G>A | G239S | LHON | Uncertain significance · confirmed | 0 |
| m.13063G>A | V243I | Adult-onset Encephalopathy / Ataxia | Uncertain significance · reported | 2 |
| m.13084A>T | S250C | MELAS / Leigh Disease | Uncertain significance · reported | 0 |
| m.13091T>C | M252T | MELAS+Migraine | Reported | 0 |
| m.13094T>C | V253A | Ataxia+PEO / MELAS, LD, LHON, myoclonus, fatigue | Pathogenic · confirmed | 1 |
| m.13112T>C | L259S | Leigh Disease | Reported | 0 |
| m.13135G>A | A267T | Possible HCM susceptibility / PCOS patients | Reported | 663 |
| m.13138G>A | E268K | Possible LHON modulator | Reported | 0 |
| m.13204G>A | V290I | Peripheral neuropathy of T2 diabetes | Reported | 46 |
| m.13268G>A | G311E | Possible ROS inducer-triggered lung cancer cell death | Reported | 0 |
| m.13271T>C | L312P | Exercise intolerance (EXIT) | Reported | 1 |
| m.13276A>G | M314V | MIDD+retinopathy | Conflicting reports | 1,959 |
| m.13289G>A | G318D | MELAS | Reported | 0 |
| m.13340T>C | F335S | LHON | Reported | 3 |
| m.13345G>A | A337T | LHON | Reported | 0 |
| m.13376T>C | I347T | MELAS w medial temporal lobe atrophy | Reported | 2 |
| m.13379A>G | H348R | LHON | Uncertain significance · confirmed | 0 |
| m.13379A>C | H348P | LHON | Uncertain significance · reported | 0 |
| m.13511A>T | K392M | Leigh-like syndrome | Reported | 0 |
| m.13513G>A | D393N | Leigh Disease / MELAS / LHON-MELAS Overlap Syndrome / negative association w Carotid Atherosclerosis | Pathogenic · confirmed | 1 |
| m.13514A>G | D393G | Leigh Disease / MELAS / Ca2+ downregulation | Likely pathogenic · confirmed | 0 |
| m.13528A>G | T398A | LHON-like, LHON, MELAS | Likely benign · reported | 78 |
| m.13565C>T | S410F | Found in MELAS patient | Reported | 78 |
| m.13580C>G | A415G | Thyroid Cancer | Reported | 0 |
| m.13590G>A | L418L | Possible protective factor for high altitude sickness / PCOS patient | Reported | 3,917 |
| m.13615A>G | I427V | LHON | Reported | 11 |
| m.13637A>G | Q434R | Possible LHON factor | Reported | 612 |
| m.13702C>G | R456G | Possible LHON helper (one 14484 patient) | Reported | 20 |
| m.13708G>A | A458T | LHON / Increased MS risk / higher freq in PD-ADS / PCOS patient / hypothyroidism | Conflicting reports | 4,893 |
| m.13712C>T | A459V | Possible LHON helper (one 11778 patient) | Reported | 11 |
| m.13730G>A | G465E | LHON | Uncertain significance · reported | 0 |
| m.13759G>A | A475T | Possible LHON factor | Reported | 2,310 |
| m.13831C>A | L499M | Thyroid Cancer Cell Line | Reported | 3 |
| m.13849A>C | N505H | MELAS | Reported | 3 |
| m.13966A>G | T544A | Greater risk with hg X of end-stage kidney disease | Reported | 903 |
| m.13967C>T | T544M | Possible LHON factor | Reported | 208 |
| m.14002A>G | T556A | High altitude pulmonary edema susceptibility | Reported | 151 |
| m.14063T>C | I576T | Potentially functional variant cosegregating with LHON3635A | Reported | 26 |
| m.14091A>T | K585N | Developmental delay, seizure, hearing loss, diabetes | Reported | 0 |
As of 2026-10-07 — a dated copy; MITOMAP can’t be fetched live, and the live table may be newer.
Source: MITOMAP (mitomap.org), CC BY 3.0
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →Trials that enrol by condition rarely name the gene: mitochondrial disease · Leigh syndrome
External Resources
Links to major genomics databases and tools